title: Propranolol inhibits the spontaneous closure of the ductus arteriosus in newborn rats.
abstract: Newborn rats delivered by cesarean section were given subcutaneously propranolol (PRO), a beta-adrenergic blocker, (1) immediately or (2) 180 min after delivery. The diameter of the ductus arteriosus (DA) of the newborn pups was calibrated at 30, 60 and 90 min after the PRO-administration. The results were as follows: (1) the DA calibers of the pups given 0.2, 1.0., 5.0 mg/kg PRO immediately after cesarean delivery remained significantly larger than those of controls in a dose-dependent manner for 30 min after treatment. In the 5 mg/kg group, the enlargement of the DA was prolonged for 90 min after treatment. (2) In untreated pups, the DA completely closed by 180 min after cesarean delivery. The DA was not affected by the administration of 5 mg/kg PRO at 3 hr after delivery. It was concluded that, PRO inhibits the spontaneous constriction of the DA, suggesting an important role of beta-adrenergic stimulation on the spontaneous closure of the DA in newborn rats.
authors.affiliation: Department of Anatomy II, Azabu University School of Veterinary Medicine, Kanagawa, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Arishima
authors.forename: T
authors.initials: T
authors.lastname: Takizawa
authors.forename: T
authors.initials: T
authors.lastname: Oda
authors.forename: M
authors.initials: M
authors.lastname: Yamamoto
authors.forename: H
authors.initials: H
authors.lastname: Togashi
authors.forename: H
authors.initials: H
authors.lastname: Somiya
authors.forename: Y
authors.initials: Y
authors.lastname: Eguchi
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D000831:Animals, Newborn / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D004373:Ductus Arteriosus / Q000187:drug effects* / Q000502:physiology; D005260:Female; D011433:Propranolol / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar / Q000502:physiology*; D013997:Time Factors; D014661:Vasoconstriction / Q000187:drug effects / Q000502:physiology; D014665:Vasodilator Agents / Q000494:pharmacology
chemical_list: D000319:Adrenergic beta-Antagonists; D014665:Vasodilator Agents; D011433:Propranolol